Announcements & Notifications
Summary of COVID-19 vaccines with Emergency Use Authorization (EUA) in Bhutan
March 19th, 2021Please click on the link below to view the summary: Summary of COVID-19 vaccines with Emergency Use Authorization (EUA) in Bhutan
» read moreDraft Guideline for Advertisement of Medical Products for comments
March 3rd, 2021We are pleased to share the draft Guideline for Advertisement of Medical Products for comments and suggestions from relevant stakeholders. You may send your comments or views on the draft document latest by 31st March, 2021 to pmcd@dra.gov.bt. Please click here to view the Draft Guideline for Advertisement of Medical Products
» read moreVacancy Announcement-Reschedule
February 3rd, 2021With reference to the postponement of the date of application submission No. DRA/D4b/16-PRO(Adv)2021/444 dated December 30, 2020, the Drug Regulatory Authority is pleased to reschedule the last date for submission of application for the post of Chief Regulatory Officer, Post Marketing Control Division to 9th February 2021. However, those who have already submitted the application […]
» read morePress Brief On Emergency Use Authorization for Covishield
January 23rd, 2021The Drug Regulatory Authority (DRA) on 21 January 2021 granted Emergency Use Authorization for Covishield™ manufactured by Serum Institute of India. The authorization was based on recommendation of the Drugs Technical Advisory Committee (DTAC) and approval ofHon’ble Chairperson, Bhutan Medicines Board. DRA has reviewed the data of the National Regulatory Authority for AstraZeneca/Oxford vaccine and […]
» read moreRegulatory Notification on Emergency Use Authorization procedure and conditions for Deployment of COVID-19 Vaccines
January 17th, 2021Drug Regulatory Authority (DRA) is pleased to issue a guidance document on Emergency Use Authorization procedure and conditions for Deployment of COVID-19 Vaccines. This procedure is effective from 10 January 2021. The decision to grant the Emergency Use Authorization (EUA) of COVID-19 vaccines is contingent to fulfilling the following: The COVID-19 vaccine should be listed […]
» read moreContact Details of Focal Person for Identified Regulatory Services During the Lockdown
January 9th, 2021With the announcement of nationwide, the Drug Regulatory Authority (DRA) hereby notifies the general public that DRA office will remain closed and the work from home mechanism will be reinstituted till further directives from the government. For matters that are urgent and require immediate action, please contact the following focal person(s). Sl.No Identified RegulatoryServices Focal […]
» read morePostponement of date of application submission
December 30th, 2020This has reference to our vacancy announcement No. DRA/D4b/16-PRO(Adv)/20-21/440 dated December 16, 2020 on the position of Chief Regulatory Officer, Post Marketing Control Division. We would like to inform that the last date of application submission slated for December 31, 2020 has been deferred indefinitely due to the current Covid-19 pandemicsituation. The office will reschedule […]
» read moreVacancy Announcement for the Post of Chief Regulatory Officer, Post-Marketing Control Division
December 16th, 2020The office of Drug Regulatory Authority, Thimphu is pleased to announce the following vacancy for in-service recruitment: Sl.# Position Title Position Level No. of Post Qualification Remarks 1 Chief Regulatory Officer, Post-Marketing Control Division P1 1 Bachelor’s Degree in relevant Field. Preferably Pharmaceutical research & policy (Technical Service Group) Open Competition Interested in-service civil servants […]
» read moreRoyal Civil Service Award and DRA Award Ceremony 2020
December 3rd, 2020In a simple ceremony, following 3 officials were awarded with the Royal Civil Service Award(Bronze) by the Drug Controller. Ms. Kuenzang Wangmo, HRO; Mr. Thinley Dorji, Sr. ICT Technical Associate III ; and Ms. Tashi Yangzom, Administrative Assistant Mr. Tashi Dhendrup, Regulatory Officer also received a congratulatory certificate for his outstanding performance in FY2019-20. We […]
» read moreDrug Regulatory Authority welcomed Mr.Wangdi Gyeltshen as the new Director
November 16th, 2020Drug Regulatory Authority welcomed Mr.Wangdi Gyeltshen as the new Director on November 12, 2020. He was formerly serving as Chief Program Officer, NCDD, Ministry of Health. Tashi Delek!
» read more